insights_auto
Why is ORX down 2.47%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEKÂ 13.40
arrow_downward
-2.47%(-0.34) 1D
Oct 2, 5:29:48 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 14.28
High
SEKÂ 14.28
Low
SEKÂ 13.30
Mkt. cap
470.70M
Avg. vol.
42.95K
Volume
0.00
P/E ratio
0.57
52-wk high
SEKÂ 43.40
52-wk low
SEKÂ 12.20
EPS
SEKÂ 23.61
Shares outstanding
35.13M
No. of employees
61
Open
SEKÂ 14.28
High
SEKÂ 14.28
Low
SEKÂ 13.30
Mkt. cap
470.70M
Avg. vol.
42.95K
Volume
0.00
P/E ratio
0.57
52-wk high
SEKÂ 43.40
52-wk low
SEKÂ 12.20
EPS
SEKÂ 23.61
Shares outstanding
35.13M
No. of employees
61
News stories
From web sources and news partners
bloomingbit
·
21 minutes ago
UK’s OpenPayd Targets Nasdaq Listing This Year via Titan Acquisition Merger, Speeds US Expansion
Simply Wall Street
·
1 hour ago
What Had To Hold Up For OptimizeRx (OPRX) And What Broke First?
TradingKey
·
59 minutes ago
S&P 500 vs. Nasdaq 100: Which Is Better for Long-Term Investment?
Business Insider
·
17 hours ago
The NYSE's Most Famous Floor Trader Says AI Can't Take His Job
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees61
Founded1995
Headquarters-
SectorPharmaceutical industry
Websiteorexo.com